vs
PUMA BIOTECHNOLOGY, INC.(PBYI)とVelocity Financial, Inc.(VEL)の財務データ比較。上の社名をクリックして会社を切り替えられます
PUMA BIOTECHNOLOGY, INC.の直近四半期売上が大きい($75.5M vs $51.6M、Velocity Financial, Inc.の約1.5倍)。Velocity Financial, Inc.の前年同期比売上増加率が高い(32.8% vs 27.7%)。Velocity Financial, Inc.の直近四半期フリーキャッシュフローが多い($17.9M vs $14.4M)。過去8四半期でVelocity Financial, Inc.の売上複合成長率が高い(32.3% vs 31.3%)
プーマ・バイオテクノロジーは上場済みの生物医薬品企業で、本社はアメリカ合衆国カリフォルニア州ロサンゼルスに位置し、革新的な医薬品の研究開発を中心に事業を展開しています。
Velocity Financial, Inc.は米国に本社を置く不動産金融企業で、主に住宅投資物件向けの専門的なモーゲージローンソリューションを提供しています。米国全土の独立系モーゲージブローカーと提携し、不動産投資家のニーズに合わせた短期ブリッジローンや長期賃貸物件向け融資商品を提供しています。
PBYI vs VEL — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $75.5M | $51.6M |
| 純利益 | — | $34.8M |
| 粗利率 | 69.3% | — |
| 営業利益率 | 22.7% | 97.0% |
| 純利益率 | — | 67.3% |
| 売上前年比 | 27.7% | 32.8% |
| 純利益前年比 | — | 67.0% |
| EPS(希薄化後) | $0.26 | $0.90 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $75.5M | $51.6M | ||
| Q3 25 | $54.5M | $49.1M | ||
| Q2 25 | $52.4M | $47.6M | ||
| Q1 25 | $46.0M | $37.5M | ||
| Q4 24 | $59.1M | $38.9M | ||
| Q3 24 | $80.5M | $35.1M | ||
| Q2 24 | $47.1M | $32.4M | ||
| Q1 24 | $43.8M | $29.5M |
| Q4 25 | — | $34.8M | ||
| Q3 25 | $8.8M | $25.4M | ||
| Q2 25 | $5.9M | $26.0M | ||
| Q1 25 | $3.0M | $18.9M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | $20.3M | $15.8M | ||
| Q2 24 | $-4.5M | $14.8M | ||
| Q1 24 | $-4.8M | $17.3M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 97.0% | ||
| Q3 25 | 17.6% | 72.1% | ||
| Q2 25 | 12.7% | 71.3% | ||
| Q1 25 | 8.7% | 71.7% | ||
| Q4 24 | 22.6% | 82.5% | ||
| Q3 24 | 27.4% | 60.6% | ||
| Q2 24 | -4.6% | 61.3% | ||
| Q1 24 | -5.3% | 78.8% |
| Q4 25 | — | 67.3% | ||
| Q3 25 | 16.2% | 51.7% | ||
| Q2 25 | 11.2% | 54.6% | ||
| Q1 25 | 6.5% | 50.4% | ||
| Q4 24 | — | 53.5% | ||
| Q3 24 | 25.2% | 45.1% | ||
| Q2 24 | -9.6% | 45.6% | ||
| Q1 24 | -11.0% | 58.5% |
| Q4 25 | $0.26 | $0.90 | ||
| Q3 25 | $0.17 | $0.65 | ||
| Q2 25 | $0.12 | $0.69 | ||
| Q1 25 | $0.06 | $0.51 | ||
| Q4 24 | $0.40 | $0.56 | ||
| Q3 24 | $0.41 | $0.44 | ||
| Q2 24 | $-0.09 | $0.42 | ||
| Q1 24 | $-0.10 | $0.49 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $97.5M | $92.1M |
| 総負債低いほど良い | $22.7M | — |
| 株主資本純資産 | $130.3M | $672.5M |
| 総資産 | $216.3M | $7.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.17× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $97.5M | $92.1M | ||
| Q3 25 | $94.4M | $99.0M | ||
| Q2 25 | $96.0M | $79.6M | ||
| Q1 25 | $93.2M | $51.7M | ||
| Q4 24 | $101.0M | $49.9M | ||
| Q3 24 | $96.7M | $44.1M | ||
| Q2 24 | $96.8M | $47.4M | ||
| Q1 24 | $107.2M | $34.8M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $672.5M | ||
| Q3 25 | $115.3M | $634.3M | ||
| Q2 25 | $104.7M | $597.9M | ||
| Q1 25 | $97.1M | $563.2M | ||
| Q4 24 | $92.1M | $516.9M | ||
| Q3 24 | $71.1M | $484.6M | ||
| Q2 24 | $48.5M | $471.3M | ||
| Q1 24 | $51.0M | $452.9M |
| Q4 25 | $216.3M | $7.4B | ||
| Q3 25 | $202.9M | $7.0B | ||
| Q2 25 | $194.9M | $6.5B | ||
| Q1 25 | $196.2M | $6.0B | ||
| Q4 24 | $213.3M | $5.5B | ||
| Q3 24 | $220.7M | $5.2B | ||
| Q2 24 | $205.0M | $4.9B | ||
| Q1 24 | $214.1M | $4.6B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $14.4M | $18.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $14.4M | $17.9M |
| FCFマージンFCF / 売上 | 19.1% | 34.6% |
| 設備投資強度設備投資 / 売上 | 0.0% | 0.5% |
| キャッシュ転換率営業CF / 純利益 | — | 0.52× |
| 直近12ヶ月FCF直近4四半期 | $41.7M | $40.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $14.4M | $18.2M | ||
| Q3 25 | $9.7M | $11.5M | ||
| Q2 25 | $14.1M | $7.7M | ||
| Q1 25 | $3.6M | $3.5M | ||
| Q4 24 | $15.6M | $37.8M | ||
| Q3 24 | $11.0M | $-17.6M | ||
| Q2 24 | $1.0M | $11.5M | ||
| Q1 24 | $11.2M | $10.6M |
| Q4 25 | $14.4M | $17.9M | ||
| Q3 25 | $9.7M | $11.4M | ||
| Q2 25 | $14.1M | $7.6M | ||
| Q1 25 | $3.6M | $3.5M | ||
| Q4 24 | $15.6M | $37.5M | ||
| Q3 24 | $11.0M | $-17.6M | ||
| Q2 24 | $1.0M | $11.4M | ||
| Q1 24 | — | $10.5M |
| Q4 25 | 19.1% | 34.6% | ||
| Q3 25 | 17.7% | 23.2% | ||
| Q2 25 | 26.8% | 15.9% | ||
| Q1 25 | 7.7% | 9.2% | ||
| Q4 24 | 26.4% | 96.4% | ||
| Q3 24 | 13.7% | -50.3% | ||
| Q2 24 | 2.1% | 35.1% | ||
| Q1 24 | — | 35.8% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.7% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | 1.10× | 0.45× | ||
| Q2 25 | 2.41× | 0.29× | ||
| Q1 25 | 1.21× | 0.19× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | 0.54× | -1.11× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.61× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PBYI
セグメントデータなし
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |